91 related articles for article (PubMed ID: 11695504)
1. A comparison of the physiological response to simulated altitude exposure and r-HuEpo administration.
Ashenden MJ; Hahn AG; Martin DT; Logan P; Parisotto R; Gore CJ
J Sports Sci; 2001 Nov; 19(11):831-7. PubMed ID: 11695504
[TBL] [Abstract][Full Text] [Related]
2. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes.
Parisotto R; Gore CJ; Hahn AG; Ashenden MJ; Olds TS; Martin DT; Pyne DB; Gawthorn K; Brugnara C
Int J Sports Med; 2000 Oct; 21(7):471-9. PubMed ID: 11071048
[TBL] [Abstract][Full Text] [Related]
3. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis.
Parisotto R; Wu M; Ashenden MJ; Emslie KR; Gore CJ; Howe C; Kazlauskas R; Sharpe K; Trout GJ; Xie M
Haematologica; 2001 Feb; 86(2):128-37. PubMed ID: 11224480
[TBL] [Abstract][Full Text] [Related]
4. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.
Russell G; Gore CJ; Ashenden MJ; Parisotto R; Hahn AG
Eur J Appl Physiol; 2002 Mar; 86(5):442-9. PubMed ID: 11882931
[TBL] [Abstract][Full Text] [Related]
5. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
[TBL] [Abstract][Full Text] [Related]
6. Simulated moderate altitude elevates serum erythropoietin but does not increase reticulocyte production in well-trained runners.
Ashenden MJ; Gore CJ; Dobson GP; Boston TT; Parisotto R; Emslie KR; Trout GJ; Hahn AG
Eur J Appl Physiol; 2000 Mar; 81(5):428-35. PubMed ID: 10751105
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
[TBL] [Abstract][Full Text] [Related]
8. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.
Ashenden MJ; Gore CJ; Parisotto R; Sharpe K; Hopkins WG; Hahn AG
Haematologica; 2003 Sep; 88(9):1053-62. PubMed ID: 12969814
[TBL] [Abstract][Full Text] [Related]
9. Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.
Varlet-Marie E; Audran M; Lejeune M; Bonafoux B; Sicart MT; Marti J; Piquemal D; Commes T
Haematologica; 2004 Aug; 89(8):991-7. PubMed ID: 15339684
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response].
León Molinari P; Jiménez Monteagudo M; Barona Zamora P; Riol Diego M; Castro Paz L; Sierrasesúmaga Ariznavarreta L
An Esp Pediatr; 1998 Jul; 49(1):17-22. PubMed ID: 9718761
[TBL] [Abstract][Full Text] [Related]
11. Effect of pre-competition and altitude training on blood models used to detect erythropoietin abuse by athletes.
Ashenden MJ; Sharpe K; Schoch C; Schumacher YO
Haematologica; 2004 Aug; 89(8):1019-20. PubMed ID: 15339692
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin administration does not influence the GH--IGF axis or makers of bone turnover in recreational athletes.
Nelson AE; Howe CJ; Nguyen TV; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
Clin Endocrinol (Oxf); 2005 Sep; 63(3):305-9. PubMed ID: 16117818
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte aspartate aminotransferase activity as a possible indirect marker for stimulated erythropoiesis in male and female athletes.
Robinson Y; Cristancho E; Böning D
Lab Hematol; 2007; 13(2):49-55. PubMed ID: 17573281
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin and autologous blood donation.
Levine EA; Rosen AL; Gould SA; Sehgal LR; Egrie JC; Browne JK; Sehgal HL; Moss GS
Surgery; 1988 Aug; 104(2):365-9. PubMed ID: 3400066
[TBL] [Abstract][Full Text] [Related]
16. American College of Sports Medicine position stand. The use of blood doping as an ergogenic aid.
Sawka MN; Joyner MJ; Miles DS; Robertson RJ; Spriet LL; Young AJ
Med Sci Sports Exerc; 1996 Jun; 28(6):i-viii. PubMed ID: 8926864
[TBL] [Abstract][Full Text] [Related]
17. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis.
Brugnara C; Colella GM; Cremins J; Langley RC; Schneider TJ; Rutherford CJ; Goldberg MA
J Lab Clin Med; 1994 May; 123(5):660-7. PubMed ID: 8195672
[TBL] [Abstract][Full Text] [Related]
18. Haematocrit in elite athletes.
Vergouwen PC; Collée T; Marx JJ
Int J Sports Med; 1999 Nov; 20(8):538-41. PubMed ID: 10606218
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietic response induced by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal surgery.
Braga M; Gianotti L; Gentilini O; Vignali A; Di Carlo V
Hepatogastroenterology; 1997; 44(15):685-90. PubMed ID: 9222672
[TBL] [Abstract][Full Text] [Related]
20. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
